ClinicalTrials.gg
CompletedNCT06310603Updated Nov 6, 2026

Determinants and Outcomes of High vs. Low Ultra-processed Feeding

An interventional study of Low-Processed Food Diet in Healthy Nutrition, sponsored by Oklahoma State University. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Oklahoma State University · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Aug 2023, registered Dec 2023).
Updated Nov 6, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn about, test, and compare health outcomes of high vs. low-processed feeding. The main question[s] it aims to answer are:

  • Does consuming a diet rich in unprocessed food improve various health outcomes? Participants will either be instructed to consume a diet rich in unprocessed food for 6 months, or consume their typical diet for 6 months. At various points in the study there will be metabolic health data collected.

If there is a comparison group: Researchers will compare the low-processed group to the typical diet group to see if there are improvements in metabolic health.

02

Conditions studied

  • Healthy Nutrition
03

In context

Lead sponsor

Oklahoma State University is the lead sponsor of 39 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • rural county resident
  • not meeting physical activity guidelines for adults
  • consuming a typical Western diet (rich in UPF)

Exclusion criteria

Exclusion Criteria:

  • chronic diseases
  • tobacco, vape, or illicit drug use
  • overly active
  • already on a restrictive diet (e.g., keto, intermittent fasting)
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Low-Processed Food Group

    Other: Low-Processed Food Diet

  • No intervention
    Typical Diet Group

Interventions

  • OtherLow-Processed Food Diet

    Participants that receive intervention will be instructed to eat a diet rich in unprocessed/minimally-processed foods, as described by the NOVA food classification system

06

What researchers measure

Primary outcomes

  1. Body Weight

    Using a standard scale, body weight in kg will be assessed

    Time frame: 1 year

  2. Body Composition

    Using Dual-energy X-ray absorptiometry(DXA), body composition will be assessed

    Time frame: 1 year

  3. Fat Mass Percentage

    Using Dual-energy X-ray absorptiometry(DXA), fat mass percentage will be assessed

    Time frame: 1 year

  4. Fat-Free Mass Percentage

    Using Dual-energy X-ray absorptiometry(DXA), fat-free mass will be assessed

    Time frame: 1 year

Secondary outcomes

  1. Triglyceride Levels

    Blood draw followed by a Piccolo scan will analyze Triglyceride levels in the blood

    Time frame: 1 year

  2. Glucose Levels

    Blood draw followed by a Piccolo scan will analyze glucose in the blood

    Time frame: 1 year

  3. Cholesterol Levels

    Blood draw followed by a Piccolo scan will analyze glucose in the blood

    Time frame: 1 year

  4. HDL

    Blood draw followed by a Piccolo scan will analyze HDL in the blood

    Time frame: 1 year

  5. LDL

    Piccolo scan will analyze LDL in the blood

    Time frame: 1 year

  6. Alanine transaminase (ALT)

    Blood draw followed by a Piccolo scan will analyze ALT in the blood

    Time frame: 1 year

  7. Aspartate transaminase (AST)

    Blood draw followed by a Piccolo scan will analyze AST in the blood

    Time frame: 1 year

Other outcomes

  1. Energy Intake

    3-Day Food Logs will record caloric intake at various points

    Time frame: 1 year

  2. Energy Expenditure

    Resting Metabolic Rate will be used to find resting energy expenditure and an accelerometer will measure expended energy through fitness, combined these will show energy expenditure

    Time frame: 1 year

  3. Gut Microbiome Collection

    Stool kits administered for fecal collection will be used for gut microbiome collection

    Time frame: 1 year

07

Study locations

1 site
  • Laboratory for Applied Nutrition and Exercise Science (LANES)
    Stillwater, Oklahoma 74075, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Aug 2023 to primary completion in Jun 2026, 34 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 6, 2026: primary completion May 2025 → Jun 2026 and completion Aug 2025 → Jun 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 13, 2023
First posted
Mar 15, 2024
StartActual
Aug 9, 2023
Primary completionActual
Jun 30, 2026was May 2025
CompletionActual
Jun 30, 2026was Aug 2025
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 6, 2026
Primary completion
May 31, 2025→Jun 30, 2026 (actual)
Nov 6, 2026
Study completion
Aug 9, 2025→Jun 30, 2026 (actual)
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Active, not recruiting→Completed
    Primary completion May 31, 2025→Jun 30, 2026 (now actual)
    Study completion Aug 9, 2025→Jun 30, 2026 (now actual)
    + 2 other changes: verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06310603
Lead sponsor
Oklahoma State University
Responsible party
Sponsor
First posted
Mar 15, 2024
Start date
Aug 9, 2023
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026
Last update
Nov 6, 2026

Study contacts

Sam Emerson, PhD
principal investigator · Oklahoma State University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion